Traci McCarty | executive |
Alexander Hardy | executive |
Henry Fuchs | executive |
Brian Mueller | executive |
Philip Nadeau | analyst |
Geoffrey Meacham | analyst |
Salveen Richter | analyst |
Christopher Raymond | analyst |
Jessica Fye | analyst |
Joseph Schwartz | analyst |
Huidong Wang | analyst |
Jeffrey Ajer | executive |
Eliana Merle | analyst |
Paul Matteis | analyst |
Mohit Bansal | analyst |
Vikram Purohit | analyst |
Lachlan Hanbury-Brown | analyst |
Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the BioMarin Pharmaceutical First Quarter 2024 Conference Call. Today's conference is being recorded. [Operator Instructions] At this time, I'd like to turn the conference over to Traci McCarty, Group Vice President, Investor Relations. Please go ahead.